A Study of MKC-442 in HIV-Positive Patients

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Emivirine

Sponsors
All Listed Sponsors
lead

Triangle Pharmaceuticals

INDUSTRY

NCT00002413 - A Study of MKC-442 in HIV-Positive Patients | Biotech Hunter | Biotech Hunter